Quarterly rpt on consolidated results for the financial period ended 30/9/2004

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/09/2004
Quarter3
Financial Year End31/12/2004
The figureshave not been audited

Attachments

pharma_klse0409_final.doc
383 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2004 
30/09/2003 
30/09/2004 
30/09/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
229,265
156,200
599,214
465,987
2Profit/(loss) before tax
22,581
16,917
59,514
48,177
3Profit/(loss)
after tax and minority
interest
14,201
11,226
37,467
31,261
4Net profit/(loss) for
the period
14,201
11,226
37,467
31,261
5Basic earnings/(loss) per share (sen)
13.99
11.21
37.06
31.24
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.5300
2.2200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced26 Nov 2004  
CategoryFinancial Results
Reference NoCC-041126-51E6F